Cargando…

Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): protocol for identification of novel biomarkers via neurophysiology

BACKGROUND: Electroconvulsive therapy (ECT) is the most effective treatment for treatment-resistant depression (TRD), especially for acute suicidal ideation, but the associated cognitive adverse effects and negative stigma limit its use. Another seizure therapy under development is magnetic seizure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daskalakis, Zafiris J., McClintock, Shawn M., Hadas, Itay, Kallioniemi, Elisa, Zomorrodi, Reza, Throop, Alanah, Palmer, Lucy, Farzan, Faranak, Thorpe, Kevin E., Tamminga, Carol, Blumberger, Daniel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Update
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666076/ https://www.ncbi.nlm.nih.gov/pubmed/34895296 http://dx.doi.org/10.1186/s13063-021-05873-7

Ejemplares similares

Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy
por: Daskalakis, Zafiris J., et al.
Publicado: (2021)

Subgenual cingulate connectivity and hippocampal activation are related to MST therapeutic and adverse effects
por: Hadas, Itay, et al.
Publicado: (2020)

Modulation of functional network properties in major depressive disorder following electroconvulsive therapy (ECT): a resting-state EEG analysis
por: Hill, Aron T., et al.
Publicado: (2020)

Selective modulation of brain network dynamics by seizure therapy in treatment-resistant depression
por: Atluri, Sravya, et al.
Publicado: (2018)

Magnetic seizure therapy and electroconvulsive therapy increase aperiodic activity
por: Smith, Sydney E., et al.
Publicado: (2023)

Magnetic seizure therapy and electroconvulsive therapy increase aperiodic activity
por: Smith, Sydney E., et al.
Publicado: (2023)

Magnetic Seizure Therapy for Suicidality in Treatment-Resistant Depression
por: Weissman, Cory R., et al.
Publicado: (2020)

Neurophysiological Biomarkers in Schizophrenia—P50, Mismatch Negativity, and TMS-EMG and TMS-EEG
por: Kim, Helena K., et al.
Publicado: (2020)

Evaluation of short interval cortical inhibition and intracortical facilitation from the dorsolateral prefrontal cortex in patients with schizophrenia
por: Noda, Yoshihiro, et al.
Publicado: (2017)

Characterization of the influence of age on GABA(A) and glutamatergic mediated functions in the dorsolateral prefrontal cortex using paired-pulse TMS-EEG
por: Noda, Yoshihiro, et al.
Publicado: (2017)

Association of Repetitive Transcranial Magnetic Stimulation Treatment With Subgenual Cingulate Hyperactivity in Patients With Major Depressive Disorder: A Secondary Analysis of a Randomized Clinical Trial
por: Hadas, Itay, et al.
Publicado: (2019)

Neurophysiological mechanisms of deep brain stimulation across spatiotemporal resolutions
por: Neumann, Wolf-Julian, et al.
Publicado: (2023)

Isolating sensory artifacts in the suprathreshold TMS-EEG signal over DLPFC
por: Poorganji, Mohsen, et al.
Publicado: (2023)

Magnetic Seizure Therapy in Treatment-Resistant Schizophrenia: A Pilot Study
por: Tang, Victor M., et al.
Publicado: (2018)

Baseline markers of cortical excitation and inhibition predict response to theta burst stimulation treatment for youth depression
por: Dhami, Prabhjot, et al.
Publicado: (2023)

Insula H-coil deep transcranial magnetic stimulation in severe and enduring anorexia nervosa (SE-AN): a pilot study
por: Knyahnytska, Yuliya O, et al.
Publicado: (2019)

Pre-Stimulus Power but Not Phase Predicts Prefrontal Cortical Excitability in TMS-EEG
por: Poorganji, Mohsen, et al.
Publicado: (2023)

Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression
por: Sun, Yinming, et al.
Publicado: (2018)

Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data
por: Weissman, Cory R., et al.
Publicado: (2021)

Characterizing Long Interval Cortical Inhibition over the Time-Frequency Domain
por: Garcia Dominguez, Luis, et al.
Publicado: (2014)

M11. ALTERED TRANSCRANIAL MAGNETIC STIMULATION ELECTROENCEPHALOGRAPHIC MARKERS IN SCHIZOPHRENIA
por: Voineskos, Daphne, et al.
Publicado: (2020)

Alcohol Impairs N100 Response to Dorsolateral Prefrontal Cortex Stimulation
por: Loheswaran, Genane, et al.
Publicado: (2018)

Pharmacological Modulation of Long-Term Potentiation-Like Activity in the Dorsolateral Prefrontal Cortex
por: Salavati, Bahar, et al.
Publicado: (2018)

Impairment of Neuroplasticity in the Dorsolateral Prefrontal Cortex by Alcohol
por: Loheswaran, Genane, et al.
Publicado: (2017)

The Relationship Between Cortical Inhibition and Electroconvulsive Therapy in the Treatment of Major Depressive Disorder
por: Voineskos, Daphne, et al.
Publicado: (2016)

The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial
por: Knyahnytska, Yuliya, et al.
Publicado: (2022)

Non-linear Entropy Analysis in EEG to Predict Treatment Response to Repetitive Transcranial Magnetic Stimulation in Depression
por: Shalbaf, Reza, et al.
Publicado: (2018)

Single-Pulse Transcranial Magnetic Stimulation-Evoked Potential Amplitudes and Latencies in the Motor and Dorsolateral Prefrontal Cortex among Young, Older Healthy Participants, and Schizophrenia Patients
por: Noda, Yoshihiro, et al.
Publicado: (2021)

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer: update to study protocol with follow-up extension
por: Sawka, Anna M., et al.
Publicado: (2015)

Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression: The FOUR-D Randomized Noninferiority Clinical Trial
por: Blumberger, Daniel M., et al.
Publicado: (2022)

The Effect of Repetitive Transcranial Magnetic Stimulation on Gamma Oscillatory Activity in Schizophrenia
por: Barr, Mera S., et al.
Publicado: (2011)

An internal pilot study for a randomized trial aimed at evaluating the effectiveness of iron interventions in children with non-anemic iron deficiency: the OptEC trial
por: Abdullah, Kawsari, et al.
Publicado: (2015)

Management of Treatment-Resistant Depression: Challenges and Strategies
por: Voineskos, Daphne, et al.
Publicado: (2020)

Reduced Prefrontal Short—Latency Afferent Inhibition in Older Adults and Its Relation to Executive Function: A TMS-EEG Study
por: Noda, Yoshihiro, et al.
Publicado: (2017)

Predictors of remission after repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: An analysis from the randomised non-inferiority THREE-D trial
por: Trevizol, Alisson P., et al.
Publicado: (2020)

Resting-State Isolated Effective Connectivity of the Cingulate Cortex as a Neurophysiological Biomarker in Patients with Severe Treatment-Resistant Schizophrenia
por: Wada, Masataka, et al.
Publicado: (2020)

Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion
por: Dobek, Christine E, et al.
Publicado: (2015)

Characterizing and Modulating Brain Circuitry through Transcranial Magnetic Stimulation Combined with Electroencephalography
por: Farzan, Faranak, et al.
Publicado: (2016)

Mst1 and Mst2 kinases: regulations and diseases
por: Qin, Funiu, et al.
Publicado: (2013)

Investigating Cortical Inhibition in First-Degree Relatives and Probands in Schizophrenia
por: Radhu, Natasha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tvtguf5qrhhv8j3muljvs4u5p3